OBJECTIVES: To assess the feasibility and the safety of conservative surgery to treat spermatic @entity602 . METHODS: @entity1 undergoing inguinoscrotal exploration in 10 different Urological Centers with diagnosis of @entity1822 were enrolled. Preoperative evaluation included physical examination, Scrotal US, Abdominal CT and Scrotal MRI in selected cases. @entity1 underwent organ sparing surgery or orchiectomy in case of intraoperative FSE was positive for a local infiltration. Data collected were: age, presence of infiltration, length of the lesion, number of lesions, definitive histological outcome, pre and postoperative @entity251 level. Follow up was performed with abdomen CT scan and scrotal US. RESULTS: From January 2007 to December 2013, 23 @entity1 (mean age: 64.7  yrs) were diagnosed with spermatic @entity602 . Each @entity1 underwent scrotal US. 10 @entity1 underwent radical orchiectomy and 13 @entity1 underwent conservative surgery. Mean follow up was 36.5 months. 5 @entity1 (21.7%) developed a recurrent disease, 18 @entity1 (78.3%) had a negative follow up (mean time: 40.8 months). Statistical analysis reveals that there is a significant correlation between number of lesions, length of the lesions and recurrent disease. CONCLUSIONS: Spermatic @entity602 is a rare disease. Conservative surgical treatment of spermatic @entity602 is a feasible therapeutic option for small, single and not infiltrating lesion.

Feasibility and safety of conservative surgery for the treatment of spermatic XXXX .

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity1822 :: ('MESH:D007890', 'Disease') :: ['leiomyosarcoma'] @entity602 :: ('MESH:D013118', 'Disease') :: ['cord leiomyosarcoma'] @entity251 :: ('MESH:D013739', 'Chemical') :: ['testosterone']
@entity602 :: (MESH:D013118,Disease) :: ['cord leiomyosarcoma']
